Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.
Carla L AlvesSidse EhmsenMikkel G TerpNeil PortmanMartina TuttolomondoOdd L GammelgaardMonique F HundebølKamila KaminskaLene E JohansenMartin BakGabriella HonethAna BoschElgene LimHenrik Jørn DitzelPublished in: Nature communications (2021)